Investigators report that even though there was some increase in cases of low-severity adverse events after third-dose vaccination against SARS-CoV-2 infection with mRNA vaccines, such third-dose vaccination did… read more.
Electroconvulsive therapy (ECT) led to a 47 per cent reduction suicide risk among depressed patients for a year after hospitalization. The findings were reported on April 26, 2022… read more.
Researchers report that outpatients with recent SARS-CoV-2 infection treated with Covid-19 convalescent plasma within nine days of diagnosis have achieved a decreased the incidence of hospitalization when compared… read more.
Adjunctive dapagliflozin therapy appears to improve outcomes in heart failure patients without regard to frailty status at initiation of treatment. These findings appeared on April 26, 2022 in… read more.
Researchers from a phase 2 study report that combination treatment with abemaciclib and letrozole shrinks or stabilizes tumors in a majority of subjects diagnosed with recurrent or persistent… read more.
A healthy lifestyle is not only linked with a longer life expectancy but also less frequency and length of Alzheimer’s dementia, researchers reported on April 13, 2022 in… read more.
Covid-19 patients are at increased risk of developing type 2 diabetes, researchers reported on March 21, 2022 in Diabetologia. “Put simply, this means that the relative risk of developing… read more.
Early aspirin therapy appears to reduce mortality among patients with moderate COVID-19, researchers reported on March 24, 2022 in JAMA Network Open. “This is our third study and… read more.
Canadian researchers report that troponin levels after cardiac surgery could be a significant marker for 30-day mortality risk. Their findings were published on March 2, 2022 in the… read more.
Researchers report that persistent disease of the small airways in the lungs, with yet unknown long-term effects, appears to be a possible log-term effect of COVID-19, and it… read more.
A decades-long New Zealand national data base study suggests an association between mental disorders and subsequent dementia. The findings were published on February 16, 2022 in JAMA Psychiatry…. read more.
Researchers from a phase 3 clinical trial report that addition of the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy significantly prolongs the survival of men with metastatic,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
